{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-008898","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2023-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.765146+00:00","generated_at":"2026-06-07T11:14:19.208650+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sonoma Pharmaceuticals enters into ATM equity distribution agreement with Maxim Group for up to $392,077","bullets":["ATM facility allows Sonoma to sell up to $392,077 of common stock through Maxim Group.","Maxim receives 3% commission per sale plus expense reimbursement up to $20,000.","Sales under effective S-3 registration statement (333-275311) declared effective Nov 20, 2023.","Company not obligated to sell any shares; no assurance of price, timing, or amount.","Agreement terminates upon full sale of shares or earlier per its terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-008898","json":"https://secwatch.observer/filing/0001683168-23-008898.json","markdown":"https://secwatch.observer/filing/0001683168-23-008898.md","text":"https://secwatch.observer/filing/0001683168-23-008898.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823008898/0001683168-23-008898-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823008898/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:14:19.208650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2da2d1cbc9742e4f1e24ce231d6e9dfd14bb5ea1","claim":"Sonoma Pharmaceuticals, Inc. entered into Equity Distribution Agreement with Maxim Group LLC valued at up to $392,077 (effective 2023-12-15).","evidence_excerpt":"On December 15, 2023, Sonoma Pharmaceuticals, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”), with Maxim Group LLC (“Maxim”), pursuant to which the Company may offer and sell, from time to time, through Maxim, as sales agent or principal, shares of its common stock, $0.0001 par value per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316823008898/0001683168-23-008898-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Value","value":"up to $392,077"},{"label":"Effective","value":"2023-12-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}